How A Drugmaker Gamed The System To Keep Generic Competition Away
(By Alison Kodjak for NPR) When Celgene Corp. first started marketing the drug Revlimid to treat multiple myeloma in 2006,
Read More
Part D/Prescription Drugs
CMS is initiating a National Coverage Analysis for CAR-T therapies
In 2017, the Food and Drug Administration approved the first chimeric antigen receptor (CAR)-T cell therapies, now the Centers for
Read MoreIn a first, FDA approves drug meant to mitigate symptoms of opioid withdrawal
(By Lev Facher for STAT) WASHINGTON — The Food and Drug Administration on Wednesday approved for the first time a
Read MoreChanges to Medicare Part D for 2019
When the President signed the Bipartisan Budget Act of 2018 on February 9th, this legislation affected those individuals with Medicare
Read MoreTest of Herceptin Finds Briefer Treatment Can Work, With Fewer Side Effects
(By Richard Harris for NPR) Sometimes less may be better when it comes to treatment for breast cancer. A new
Read MoreThe Senate calling into question the 340B Drug Pricing Program
The United States Senate Committee on Health, Education, Labor and Pensions (HELP) is calling into question the intent of 340B
Read MoreMedicare prescription drug spending reached $174 billion in 2016
CMS released redesigned drug price dashboards to provide information about manufacturer drug costs to provide much-needed clarity and will empower
Read MoreTrump Administration’s 3 Biggest Ideas For Lowering Drug Prices
(By Alison Kodjak for NPR) Health and Human Services Secretary Alex Azar has this pen. It’s not all that remarkable
Read MoreAmerican Patients First: Blueprint for reducing drug prices
On Friday, President Trump introduced a blueprint for reducing drug prices called ‘American Patients First”. The 50-point plan addresses four
Read MoreCan A Cocktail Of Vitamins And Steroids Cure A Major Killer In Hospitals?
(By Richard Harris for NPR) Scientists have launched two large studies to test a medical treatment that, if proven effective,
Read More